KYORIN Rimedio Co., Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

KYORIN Rimedio Co., Ltd. - overview

Established

1947

Location

-, Ishikawa, Japan

Primary Industry

Pharmaceuticals

About

Founded in 1947 and based in Kanazawa, Japan, KYORIN Rimedio Co. , Ltd. manufactures and sells pharmaceutical products, develops drug formulations, manages product portfolios, conducts quality assurance activities, supports pharmaceutical distribution, and operates research, sales, and business management functions for healthcare providers and pharmaceutical markets.


Current Investors

Development Bank of Japan, DAITO Co., Ltd., Meiji Seika Pharma

Primary Industry

Pharmaceuticals

Sub Industries

Specialty Pharmaceuticals, Pharmaceutical Research & Development, Medicinal Chemicals & Botanicals

Website

www.kyorin-rmd.co.jp

Verticals

HealthTech

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

KYORIN Rimedio Co., Ltd. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
BuyoutCompletedKYORIN Rimedio Co., Ltd.-

Displaying 1 - 1 of 1

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.